CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with ...

Electrical transcutaneous neuromodulation (eTNM) of the peroneal nerve led to fewer side effects compared with solifenacin (Vesicare) in the treatment of overactive bladder, a randomized trial showed.

Major depressive disorder (MDD) and bipolar disorder are among the leading causes of disability worldwide. However, their pathophysiological mechanisms ...

Essential tremor, one of the most common movement disorders, has long suffered from limited treatment options. Now, breakthroughs like ulixacaltamide and advances in surgical and noninvasive ...

The company's FDA-cleared wearable uses personalized nerve stimulation to treat essential tremor and Parkinson's disease.

Please provide your email address to receive an email when new articles are posted on . Artificial tears have long been the first option for patients with dry eye disease, but they only offer a ...

For people living with depression, medication and therapy can be life-changing. But for others, those traditional options don ...

Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...

The function of the lower urinary tract — to store and periodically eliminate urine — seems simple, but its neuronal control is complex and not fully understood, and dysfunction is common. Functional ...